The impact of pre-transplant fibrinogen and D-dimer levels on transplantation outcomes in autologous stem cell transplantation
Abstract
Keywords
Supporting Institution
Ethical Statement
References
- Al Hamed R, Bazarbachi AH, Malard F, Harousseau JL, Mohty M. Current status of autologous stem cell transplantation for multiple myeloma. Blood Cancer J. 2019;9(4):44. doi:10.1038/s41408-019-0205-9
- Zahid U, Akbar F, Amaraneni A, et al. A review of autologous stem cell transplantation in lymphoma. Curr Hematol Malig Rep. 2017;12(3):217-226. doi:10.1007/s11899-017-0382-1
- Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881-2892. doi:10. 1182/blood.2020008824
- Linkins LA, Takach Lapner S. Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol. 2017;39(Suppl 1):98-103. doi:10.1111/ijlh.12665
- Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer. J Am Coll Cardiol. 2017;70(19):2411-2420. doi:10.1016/j.jacc.2017.09.024
- Franchini M, Focosi D, Pezzo MP, Mannucci PM. How we manage a high D-dimer. Haematologica. 2023;109(4):1035-1045. doi:10.3324/haematol.2023.283966
- Schafer K, Goldschmidt E, Oostra D, Fish J, Russell T, Lurie F. The clinical significance of ultra-high D-dimer levels. J Vasc Surg Venous Lymphat Disord. 2022;10(1):8-13. doi:10.1016/j.jvsv.2021.06.011
- Ozen M, Yilmaz A, Cakmak V, et al. D-dimer as a potential biomarker for disease severity in COVID-19. Am J Emerg Med. 2021;40:55-59. doi: 10.1016/j.ajem.2020.12.023
Details
Primary Language
English
Subjects
Haematology
Journal Section
Research Article
Publication Date
July 30, 2025
Submission Date
June 1, 2025
Acceptance Date
June 26, 2025
Published in Issue
Year 2025 Volume: 8 Number: 4




